Allergen‐Encapsulating Nanoparticles Reprogram Pathogenic Allergen‐Specific Th2 Cells to Suppress Food Allergy
Open Access
- 9 May 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (5) , e2400237
Abstract
Food allergy is a prevalent, potentially deadly disease caused by inadvertent sensitization to benign food antigens. Pathogenic Th2 cells are a major driver for disease, and allergen‐specific immunotherapies (AIT) aim to increase the allergen threshold required to elicit severe allergic symptoms. However, the majority of AIT approaches require lengthy treatments and convey transient disease suppression, likely due to insufficient targeting of pathogenic Th2 responses. Here, the ability of allergen‐encapsulating nanoparticles to directly suppress pathogenic Th2 responses and reactivity is investigated in a mouse model of food allergy. NPs associate with pro‐tolerogenic antigen presenting cells, provoking accumulation of antigen‐specific, functionally suppressive regulatory T cells in the small intestine lamina propria. Two intravenous doses of allergen encapsulated in poly(lactide‐co‐glycolide) nanoparticles (NPs) significantly reduces oral food challenge (OFC)‐induced anaphylaxis. Importantly, NP treatment alters the fates of pathogenic allergen‐specific Th2 cells, reprogramming these cells toward CD25+FoxP3+ regulatory and CD73+FR4+ anergic phenotypes. NP‐mediated reductions in the frequency of effector cells in the gut and mast cell degranulation following OFC are also demonstrated. These studies reveal mechanisms by which an allergen‐encapsulating NP therapy and, more broadly, allergen‐specific immunotherapies, can rapidly attenuate allergic responses by targeting pathogenic Th2 cells.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 AI155678)
- National Institutes of Health (R01AI155678, T32GM007863)
This publication has 70 references indexed in Scilit:
- In vitro-induced Foxp3+CD8+ regulatory T cells suppress allergic IgE response in the gutJournal of Leukocyte Biology, 2022
- Mechanistic contributions of Kupffer cells and liver sinusoidal endothelial cells in nanoparticle-induced antigen-specific immune toleranceBiomaterials, 2022
- Inhibition of glycolysis in the presence of antigen generates suppressive antigen-specific responses and restrains rheumatoid arthritis in miceBiomaterials, 2021
- Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activationBiomaterials, 2019
- Mouse strain differences in response to oral immunotherapy for peanut allergyImmunity, Inflammation and Disease, 2019
- Prevalence and Severity of Food Allergies Among US AdultsJAMA Network Open, 2019
- In vivo reprogramming of immune cells: Technologies for induction of antigen-specific toleranceAdvanced Drug Delivery Reviews, 2017
- Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantationBiomaterials, 2014
- Intestinal Mast Cell Levels Control Severity of Oral Antigen-Induced Anaphylaxis in MiceThe American Journal of Pathology, 2012
- α4 integrins mediate lymphocyte attachment and rolling under physiologic flowCell, 1995